“The Academy of Managed Care Pharmacy (AMCP)…..released a set of recommendations that would allow biopharmaceutical companies to more easily share health care economic information (HCEI) with entities that make formulary and coverage decisions, a move that addresses the growing need to determine the "value" of new medicines.
The recommendations address restrictions in the sharing of product information that does not appear on the drug label, a prohibition that hinders decision makers from accessing HCEI on new therapies.
The recommendations are contained in the forum proceedings, published in the July issue of AMCP's Journal of Managed Care & Specialty Pharmacy (JMCP). AMCP now will lead the development of a draft guidance document to share with the FDA. This information also will be shared with Congress as it considers legislative solutions to improve sharing of HCEI.”
|Image: Little Brown Bottles by PhotoAteller|